Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Expert Review of Molecular Diagnostics|August 2, 2021
An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancerNarges Dastmalchi, Reza Safaralizadeh, Saeid Latifi-Navid, et al.Clinical and Experimental Hepatology|May 22, 2024
The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genesNasim Rahimi Farsi, Bahman Naghipour, Parviz Shahabi, et al.Molecular Biology Reports|June 9, 2026
Effects of Nicotine administration on α7nAChR, miR-124, STAT3, and inflammatory markers in Rat Lung TissueNarges Dastmalchi, Fatemeh Asaadi, Elham Karimi-Sales, et al.Life Sciences|August 10, 2020
Antioxidants with two faces toward cancerNarges Dastmalchi, Behzad Baradaran, Saeid Latifi-Navid, et al.International Immunopharmacology|May 20, 2021
Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategiesMohammad Ghanbari, Salar Momen Maragheh, Aida Aghazadeh, et al.Molecular Biology Reports|June 6, 2022
The combined restoration of miR-424-5p and miR-142-3p effectively inhibits MCF-7 breast cancer cell line via modulating apoptosis, proliferation, colony formation, cell cycle and autophagyNarges Dastmalchi, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, et al.Current Medicinal Chemistry|May 16, 2021
An Updated Review of the Cross-talk Between MicroRNAs and Epigenetic Factors in CancersNarges Dastmalchi, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, et al.Medical Oncology (Northwood, London, England)|November 11, 2021
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancerNarges Dastmalchi, Shirin Azarbarzin, Reza Safaralizadeh, et al.Pageof 4